相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of a high-throughput AlphaScreen assay measuring full-length LRRK2(G2019S) kinase activity using moesin protein substrate
Liliana Pedro et al.
ANALYTICAL BIOCHEMISTRY (2010)
Development of a mechanism-based high-throughput screen assay for leucine-rich repeat kinase 2-Discovery of LRRK2 inhibitors
Min Liu et al.
ANALYTICAL BIOCHEMISTRY (2010)
Lifespan extension in Caenorhabditis elegans by DMSO is dependent on sir-2.1 and daf-16
Xiangming Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models
Linhui Julie Su et al.
DISEASE MODELS & MECHANISMS (2010)
The Biology and Pathology of the Familial Parkinson's Disease Protein LRRK2
William Dauer et al.
MOVEMENT DISORDERS (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Neurodegenerative disorders: Insights from the nematode Caenorhabditis elegans
Maria Dimitriadi et al.
NEUROBIOLOGY OF DISEASE (2010)
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
Chen Yao et al.
NEUROBIOLOGY OF DISEASE (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions
Elisa Greggio et al.
ASN NEURO (2009)
Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2
Jason P. Covy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2009)
Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
Katerina Venderova et al.
HUMAN MOLECULAR GENETICS (2009)
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro
Christian Johannes Gloeckner et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
Chee-Hoe Ng et al.
JOURNAL OF NEUROSCIENCE (2009)
LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans
Shamol Saha et al.
JOURNAL OF NEUROSCIENCE (2009)
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
Luke S. Tain et al.
NATURE NEUROSCIENCE (2009)
Maintaining the brain: insight into human neurodegeneration from Drosophila melanogaster mutants
Derek Lessing et al.
NATURE REVIEWS GENETICS (2009)
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Yuzuru Imai et al.
EMBO JOURNAL (2008)
Ancient origin of the Parkinson disease gene LRRK2
Ignacio Marin
JOURNAL OF MOLECULAR EVOLUTION (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A Drosophila model for LRRK2-linked parkinsonism
Zhaohui Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model
Shusei Hamamichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis
Aaron D. Gitler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
Antony A. Cooper et al.
SCIENCE (2006)
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
WW Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans
SS Cao et al.
JOURNAL OF NEUROSCIENCE (2005)
The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism
PC Chin et al.
JOURNAL OF NEUROCHEMISTRY (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans
R Nass et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The discovery of potent cRaf1 kinase inhibitors
K Lackey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
分享论文
